Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on request.
References
Grimwade D, Hills RK, Moorman AV et al (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116(3):354–365
Dohner H et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4):424–447
Swerdlow SH et al (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, France
Funding
The author(s) received no financial support for the research, authorship and publication of this article.
Author information
Authors and Affiliations
Contributions
ST and KX wrote up the manuscript. ST, RB, EN, JO, RG, AW and KX critically revised the final version of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
Not required for this audit.
Informed consent
Not applicable.
Consent for publication
For this audit, consent for publication is not required.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tayabali, S., Baker, R., Nacheva, E. et al. The use of leukaemia Q-fusion gene screening assay (Q30) in the diagnostic evaluation of acute myeloid leukaemia (AML). J Hematopathol 17, 37–39 (2024). https://doi.org/10.1007/s12308-023-00571-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12308-023-00571-6